These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6977173)

  • 61. Nephritis in SLE.
    Phillips PE; Reichlin M; Mattiolo M
    N Engl J Med; 1972 Jun; 286(26):1416-7. PubMed ID: 4537400
    [No Abstract]   [Full Text] [Related]  

  • 62. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus.
    Sinico RA; Bollini B; Sabadini E; Di Toma L; Radice A
    J Nephrol; 2002; 15 Suppl 6():S20-7. PubMed ID: 12515370
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative study of anti-double stranded DNA detection by ELISA and Crithidia luciliae immunofluorescence.
    Janyapoon K; Jivakanont P; Choosang K; Surbrsing R; Charoenying V; Baithong S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):646-50. PubMed ID: 15115145
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical studies on anti-nuclear factor in the patients with systemic lupus erythematosus concerning possible role on pathogenesis].
    Kurata N
    Rinsho Ketsueki; 1972 Aug; 13(4):527-34. PubMed ID: 4539473
    [No Abstract]   [Full Text] [Related]  

  • 65. Immunoglobulin G subclass of human antinuclear antibodies.
    Tojo T; Friou GJ; Spiegelberg HL
    Clin Exp Immunol; 1970 Jan; 6(1):145-51. PubMed ID: 4984586
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Current significance of the LE-phenomenon and antinuclear seroreactions in clinical diagnosis].
    Beickert A
    Z Arztl Fortbild (Jena); 1973 Jan; 67(2):75-9. PubMed ID: 4121746
    [No Abstract]   [Full Text] [Related]  

  • 67. [Complement-binding DNA antibodies in patients with LED--an index for pathological activity].
    Fjellström KE; Wallentin L; Hood B
    Nord Med; 1971 Jul; 86(27):833-4. PubMed ID: 5314751
    [No Abstract]   [Full Text] [Related]  

  • 68. [Studies on anti-DNA antibodies associated with renal involvement by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus].
    Taman J; Yabuki T; Furuyoshi S; Takata S; Kutsuki H; Miyawaki S
    Ryumachi; 1996 Feb; 36(1):8-15. PubMed ID: 8711542
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay.
    Smeenk R; van der Lelij G; Aarden L
    Clin Exp Immunol; 1982 Sep; 49(3):603-10. PubMed ID: 6756723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Deoxyribonucleic acid and its antibodies in systemic lupus erythematosus.
    Chee YC
    Singapore Med J; 1981 Dec; 22(6):323-31. PubMed ID: 7038879
    [No Abstract]   [Full Text] [Related]  

  • 71. The value of anti-DNA antibody titers in the early diagnosis, treatment and follow-up of systemic lupus erythematosus.
    Pick AI; Levo Y; Weiss C
    Isr J Med Sci; 1974 Jul; 10(7):725-30. PubMed ID: 4137310
    [No Abstract]   [Full Text] [Related]  

  • 72. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-double-stranded DNA antibodies in the healthy elderly: prevalence and characteristics.
    Ruffatti A; Calligaro A; Del Ross T; Bertoli MT; Doria A; Rossi L; Todesco S
    J Clin Immunol; 1990 Nov; 10(6):300-3. PubMed ID: 2084144
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clinical significance of antibodies against double-strain DNA].
    Genth E
    Dtsch Med Wochenschr; 1978 Jun; 103(25):1025-7. PubMed ID: 307484
    [No Abstract]   [Full Text] [Related]  

  • 76. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical and theoretical interest of the immunochemical analysis of antinuclear antibodies in systemic lupus erythematosus.
    Tron F; Jacob L; Bach JF
    Adv Nephrol Necker Hosp; 1983; 12():215-37. PubMed ID: 6188347
    [No Abstract]   [Full Text] [Related]  

  • 78. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
    Hoffman IE; Peene I; Meheus L; Huizinga TW; Cebecauer L; Isenberg D; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
    Ann Rheum Dis; 2004 Sep; 63(9):1155-8. PubMed ID: 15308527
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of fibronectin on the Crithidia luciliae test for anti-double-stranded DNA antibodies.
    Herbert KE; Jeffery E; Scott DL
    Ann Rheum Dis; 1990 Sep; 49(9):705-7. PubMed ID: 2241287
    [TBL] [Abstract][Full Text] [Related]  

  • 80. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.